Meeting
2023 ASCO Annual Meeting
System-wide approach on biosimilars adoption in oncology: Strategic plan on switching and cost savings.
Authors
Suwicha Limvorasak
Cedars-Sinai Medical Center, Los Angeles, CA
Suwicha Limvorasak , Kyung Kim , Crystal Leung Dobbs , Edwin Melencio Posadas , Kevin Scher , Johnny Chang , Vi Kien Chiu , Marcio A. Diniz , Andre Rogatko , Hilary Teaford , Leanne Sakamoto , Bruce Vinson , Vipul Patel , Robert A. Figlin , Rita Shane , Karen L. Reckamp
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Care Delivery and Regulatory Policy
Track
Care Delivery and Quality Care
Sub Track
Practice Management
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 1600)
DOI
10.1200/JCO.2023.41.16_suppl.1600
Abstract #
1600
Poster Bd #
194
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Medicare reimbursement trends of biological reference agents and their biosimilars.
First Author: John Albaugh
Poster
2023 ASCO Annual Meeting
Biosimilar uptake and cost savings analysis before and after implementation of a pharmacist-driven substitution program within a National Community Oncology Network: One-year follow-up.
First Author: Melody Chang
Poster
2021 ASCO Quality Care Symposium
Evaluation of real-world cost savings and utilization of biosimilar drugs in a community-based oncology practice.
First Author: Amit Sanyal
Poster
2021 ASCO Quality Care Symposium
Scaled integration of FDA approved biosimilars: Closing the knowledge and adoption gaps.
First Author: David Michael Waterhouse